Selinexor is the world's first orally administered selective nuclear export inhibitor (SINE) developed by the company. By blocking the function of nuclear export protein XPO1 (CRM1), it promotes the accumulation of tumor suppressor, growth regulator, and anti-inflammatory proteins in the nucleus, thereby enhancing its anti-cancer activity in cells.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: